MagNap Clinical Trial Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.9M

  • Investors
  • 2

MagNap Clinical Trial General Information

Description

Manufacturer of a surgical device intended for the treatment of obstructive sleep apnea. The company's device specializes in offering a new minimally invasive surgical treatment for certain types of sleep apnea, enabling healthcare professionals to avail efficient and advanced surgical tools and equipment to serve their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 1600 Divisadero Street
  • San Francisco, CA 94115
  • United States
+1 (707) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MagNap Clinical Trial Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 19-Jun-2017 $2.9M 00.00 00.00 Completed Generating Revenue
To view MagNap Clinical Trial’s complete valuation and funding history, request access »

MagNap Clinical Trial Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view MagNap Clinical Trial’s complete cap table history, request access »

MagNap Clinical Trial Executive Team (2)

Name Title Board Seat Contact Info
Michael Harrison MD Founder, President & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

MagNap Clinical Trial Board Members (1)

Name Representing Role Since
Douglas Crawford Ph.D Mission Bay Capital Board Member 000 0000
To view MagNap Clinical Trial’s complete board members history, request access »

MagNap Clinical Trial Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mission Bay Capital Venture Capital Minority 000 0000 000000 0
Mission BioCapital Venture Capital Minority 000 0000 000000 0
To view MagNap Clinical Trial’s complete investors history, request access »